Metis Global Partners’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,600
| Closed | -$493K | – | 812 |
|
|
2025
Q1 | $493K | Buy |
1,600
+170
| +12% | +$52.4K | 0.01% | 593 |
|
|
2024
Q4 | $505K | Sell |
1,430
-74
| -5% | -$26.1K | 0.02% | 585 |
|
|
2024
Q3 | $539K | Sell |
1,504
-95
| -6% | -$34K | 0.02% | 558 |
|
|
2024
Q2 | $509K | Sell |
1,599
-57
| -3% | -$18.2K | 0.02% | 539 |
|
|
2024
Q1 | $380K | Sell |
1,656
-27
| -2% | -$6.2K | 0.01% | 611 |
|
|
2023
Q4 | $370K | Sell |
1,683
-131
| -7% | -$28.8K | 0.01% | 609 |
|
|
2023
Q3 | $410K | Buy |
1,814
+103
| +6% | +$23.3K | 0.02% | 574 |
|
|
2023
Q2 | $378K | Sell |
1,711
-65
| -4% | -$14.3K | 0.02% | 580 |
|
|
2023
Q1 | $398K | Sell |
1,776
-765
| -30% | -$171K | 0.03% | 534 |
|
|
2022
Q4 | $707K | Sell |
2,541
-433
| -15% | -$120K | 0.06% | 345 |
|
|
2022
Q3 | $623K | Sell |
2,974
-121
| -4% | -$25.3K | 0.1% | 229 |
|
|
2022
Q2 | $730K | Buy |
+3,095
| New | +$730K | 0.12% | 202 |
|